N-{3-[3-CYCLOPROPYL-5-(2-FLUORO-4-IODO-PHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2HP YRIDO[4,3-D]PYRIMIDIN-1 -YL]PHENYL}ACETAMIDE FOR USE IN THE TREATMENT OF CANCER

Invented are methods for treating cancer in a human in need thereof which comprises the administration of a therapeutically effective amount of N-{3-[3-cyclopropyl- 5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H- pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a sal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BEHBAHANI, ROYA, ROGAN, DEBRA ANN, HAMID, MOHAMMED R, RICHARDS, ERIC MICHAEL, OUELLET, DANIELE, PATEL, KIRAN, STREIT, MICHAEL R
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Invented are methods for treating cancer in a human in need thereof which comprises the administration of a therapeutically effective amount of N-{3-[3-cyclopropyl- 5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H- pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a salt or solvate thereof, to such human. Also invented are methods of treating cancer in a human in need thereof which comprises the administration of a therapeutically effective amount of N-{3-[3-cyclopropyl-5-(2-fluoro- 4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3- d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide to such human. L'invention concerne des méthodes de traitement du cancer chez un être humain en ayant besoin qui comprend l'administration d'une quantité thérapeutiquement efficace de N-{3-[3-cyclopropyl- 5-(2-fluoro-4-iodo-phénylamino)-6,8-diméthyl-2,4,7-trioxo-3,4,6,7-tétrahydro-2H- pyrido[4,3-d]pyrimidin-1-yl]phényl}acétamide ou d'un sel ou solvate de celui-ci à un cet être humain. L'invention concerne également des méthodes de traitement du cancer chez un être humain en ayant besoin qui comprend l'administration d'une quantité thérapeutiquement efficace de N-{3-[3-cyclopropyl-5-(2-fluoro- 4-iodo-phénylamino)-6,8-diméthyl-2,4,7-trioxo-3,4,6,7-tétrahydro-2H-pyrido[4,3- d]pyrimidin-1-yl]phényl}acétamide diméthyl sulfoxyde à cet être humain.